PLx Pharma Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and PLx Pharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days PLx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, PLx Pharma is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 22.4 M | |
| Total Cashflows From Investing Activities | 95 K |
PLx |
PLx Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in PLx Pharma on October 28, 2025 and sell it today you would earn a total of 100.00 from holding PLx Pharma or generate -100.0% return on investment over 90 days. PLx Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than PLx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PLx Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PLx Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PLx Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PLx Pharma is not yet fully synchronised with the market data | |
| PLx Pharma has some characteristics of a very speculative penny stock | |
| PLx Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.21 M. Net Loss for the year was (46.12 M) with profit before overhead, payroll, taxes, and interest of 3.4 M. | |
| PLx Pharma currently holds about 35.73 M in cash with (32.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.27. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
PLx Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PLx Stock often depends not only on the future outlook of the current and potential PLx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PLx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.7 M | |
| Cash And Short Term Investments | 69.4 M |
PLx Pharma Fundamentals Growth
PLx Stock prices reflect investors' perceptions of the future prospects and financial health of PLx Pharma, and PLx Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PLx Stock performance.
| Return On Equity | -0.75 | |||
| Return On Asset | -0.64 | |||
| Operating Margin | (14.18) % | |||
| Current Valuation | 5.49 M | |||
| Shares Outstanding | 29.14 M | |||
| Price To Earning | 52.40 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 8.21 M | |||
| EBITDA | (35.24 M) | |||
| Cash And Equivalents | 35.73 M | |||
| Cash Per Share | 1.27 X | |||
| Total Debt | 202 K | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | (32.12 M) | |||
| Earnings Per Share | (0.39) X | |||
| Total Asset | 76.64 M | |||
| Retained Earnings | (148.27 M) | |||
| Current Asset | 13.62 M | |||
| Current Liabilities | 2.4 M | |||
Things to note about PLx Pharma performance evaluation
Checking the ongoing alerts about PLx Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PLx Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PLx Pharma is not yet fully synchronised with the market data | |
| PLx Pharma has some characteristics of a very speculative penny stock | |
| PLx Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.21 M. Net Loss for the year was (46.12 M) with profit before overhead, payroll, taxes, and interest of 3.4 M. | |
| PLx Pharma currently holds about 35.73 M in cash with (32.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.27. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing PLx Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PLx Pharma's stock is overvalued or undervalued compared to its peers.
- Examining PLx Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PLx Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PLx Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PLx Pharma's stock. These opinions can provide insight into PLx Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in PLx Stock
If you are still planning to invest in PLx Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PLx Pharma's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |